UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Syndax Pharmaceuticals
SNDX
$1.82B
| $858K | ﹤0.01% |
38,387
+12,187
| +47% | +$275K |
|
|
UMH
2102
UMH Properties
UMH
$1.36B
| $854K | ﹤0.01% |
44,535
| – | – |
|
2103
First Bancorp
FBNC
$2.68B
| $854K | ﹤0.01% |
19,624
+9,191
| +88% | +$366K |
|
|
EVOP
2104
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $852K | ﹤0.01% |
30,946
-4,829
| -13% | -$130K |
|
2105
Cars.com
CARS
$660M
| $849K | ﹤0.01% |
65,504
-895
| -1% | -$11.7K |
|
2106
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $844K | ﹤0.01% |
30,340
| – | – |
|
2107
RadNet
RDNT
$5.69B
| $839K | ﹤0.01% |
38,592
-5,678
| -13% | -$115K |
|
2108
SiriusPoint
SPNT
$2.68B
| $838K | ﹤0.01% |
82,526
| – | – |
|
|
MRC
2109
DELISTED
MRC Global
MRC
| $835K | ﹤0.01% |
92,501
-15,356
| -14% | -$131K |
|
2110
CorVel
CRVL
$3.19B
| $834K | ﹤0.01% |
24,375
-3,957
| -14% | -$138K |
|
2111
Axogen
AXGN
$2.5B
| $829K | ﹤0.01% |
40,908
+888
| +2% | +$17.5K |
|
2112
Cass Information Systems
CASS
$743M
| $828K | ﹤0.01% |
17,899
| – | – |
|
2113
Skywest
SKYW
$4.34B
| $824K | ﹤0.01% |
15,129
| – | – |
|
2114
York Water
YORW
$514M
| $824K | ﹤0.01% |
16,818
| – | – |
|
|
NP
2115
DELISTED
Neenah, Inc. Common Stock
NP
| $823K | ﹤0.01% |
16,010
| – | – |
|
|
DMC
2116
Del Monte Corp
DMC
$1.45B
| $821K | ﹤0.01% |
28,690
-992
| -3% | -$26.4K |
|
2117
Alaunos Therapeutics
TCRT
$4.86M
| $820K | ﹤0.01% |
1,519
+231
| +18% | +$144K |
|
2118
CVR Energy
CVI
$3.13B
| $819K | ﹤0.01% |
42,723
+764
| +2% | +$15.5K |
|
|
ATRI
2119
DELISTED
Atrion Corp
ATRI
| $818K | ﹤0.01% |
1,276
-121
| -9% | -$80.3K |
|
|
LBAI
2120
DELISTED
Lakeland Bancorp Inc
LBAI
| $818K | ﹤0.01% |
46,919
-8,492
| -15% | -$131K |
|
2121
Purple Innovation
PRPL
$41.7M
| $816K | ﹤0.01% |
1,032
+150
| +17% | +$130K |
|
2122
Liberty Energy
LBRT
$3.25B
| $816K | ﹤0.01% |
72,273
+5,000
| +7% | +$60.1K |
|
2123
Scholastic
SCHL
$792M
| $813K | ﹤0.01% |
27,008
| – | – |
|
|
SRDX
2124
DELISTED
Surmodics
SRDX
| $812K | ﹤0.01% |
14,483
+4,553
| +46% | +$227K |
|
2125
Harmonic Inc
HLIT
$1.28B
| $806K | ﹤0.01% |
102,753
+3,000
| +3% | +$23.7K |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.